Amarin Corporation plc: Amarin Partner EddingPharm Receives

-- VASCEPA Approved by the National Medical Products Administration (NMPA) as an Adjunct to Diet to Reduce Triglyceride Levels in Adult Patients with Severe Hypertriglyceridemia (= 500 mg/dL) -- --

Related Keywords

China , Ireland , United Arab Emirates , Dublin , New Jersey , United States , Finland , Lebanon , Switzerland , Sweden , Canada , Chinese , Lisa Defrancesco , Mark Marmur , Rebecca Xu , Steven Ketchum , Environmental Sciences , European Union , Drug Administration , Nasdaq , Amarin Corporation , Clinical Development , Exchange Commission , World Heart Federation Fact Sheet , Research Development , National Medical Products Administration , Committee Of The Report On Cardiovascular Health , Cardiovascular Health , National Reimbursement Drug Listing , China National Medical Products Administration , World Heart Federation , Reduce Triglyceride Levels , Adult Patients , Severe Hypertriglyceridemia , Pharm Now Working Towards Preparing , Commercial Launch , Mainland China Expected , Mainland China , Chief Scientific Officer , Vice President , Healthy China , United Arab , Private Securities Litigation Reform Act , Securities Act , Writing Committee , Cardiovascular Disease , Amarin , Corporation , Partner , Ddingpharm , Eceives , Egulatory , Approval , Vascepa , Icosapent , Methyl , Mainland ,